PON1gene polymorphisms in patients with chronic obstructive pulmonary disease
Authors:
- 1 June 2018
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 71 (11) , 963-970
Abstract
Aims: Chronic obstructive pulmonary disease (COPD) is characterised with oxidative stress. Paraoxonase 1 (PON1) is an enzyme, coded byPON1gene, with distinctive antiatherogenic and antioxidative roles. We aimed to investigate the frequencies of Q192R, L55M and −108C>T polymorphisms and association of those polymorphisms with paraoxonase and arylesterase activities in patients with COPD.Methods: PON1genotype was determined by PCR–restriction fragment length polymorphism method. PON1 activity was measured by paraoxon and phenylacetate.Results: Only −108C>T polymorphism resulted in significantly different distribution of genotypes and alleles, with higher frequency of TT genotype and T allele in patients compared with control subjects. Moreover, T allele (OR 2.29 (95% CI 1.54 to 3.41); pPON1−108C>T polymorphism could be a potential predictor of the disease.Keywords
Funding Information
- Hrvatska Zaklada za Znanost
This publication has 39 references indexed in Scilit:
- Chronic Obstructive Pulmonary Disease and Paraoxonase-1 192 and 55 Gene PolymorphismsBiotechnology & Biotechnological Equipment, 2010
- What can naturally occurring mutations tell us about the pathogenesis of COPD?Thorax, 2009
- Paraoxonase 1: Genetics and Activities During AgingRejuvenation Research, 2008
- A common haplotype within the PON1 promoter region is associated with sporadic ALSAmyotrophic Lateral Sclerosis, 2008
- Oxidative Stress in Smokers and Non-smokersInhalation Toxicology, 2007
- Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub‐threshold pesticide exposureThe FASEB Journal, 2006
- The paraoxonase gene family and atherosclerosisFree Radical Biology and Medicine, 2005
- Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 statusPharmacogenetics, 2003
- Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNAArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997